Journal List > J Korean Ophthalmol Soc > v.54(4) > 1009643

Yoo, Kang, Kim, and Song: The Effects of Pharmacologic Pupil Dilatation on Ocular, Corneal, and Internal Aberrations

Abstract

Purpose

The present study investigates the effects of pharmacologic pupil dilatation on ocular, corneal and internal aberrations.

Methods

Sixty-two right eyes of 62 healthy participants were included in the present study. Ocular, corneal and internal aberrations were measured with a KR-1W wavefront aberrometer (Topcon Corp., Tokyo, Japan) before mydriasis in mesopic conditions. After pupil dilatation with a mydriatic drug (phenylephrine chloride 0.5% + tropicamide 0.5%) (Mydrin-P, Santen, Osaka, Japan), the measurements were repeated. The wavefront data of 4-mm and 6-mm diameter zones were analyzed. The changes of aberrations before and after mydriasis were evaluated by paired t-test.

Results

The values of ocular, corneal and internal spherical aberrations before and after mydriasis on the 4-mm diameter pupil zone were not statistically significantly different. On the 6-mm diameter zone, the ocular and internal spherical aberrations were statistically significantly different (p = 0.025, p = 0.002, respectively, paired t-test). However, the corneal aberrations did not show significant changes. The internal aberrations average before mydriasis was -0.043 (±0.21) μm and was shifted in a negative direction to -0.093 (±0.17) μm after mydriasis. The ocular aberrations average also changed toward negative after mydriasis. The high-order aberrations and astigmatism did not change significantly.

Conclusions

The ocular and internal spherical aberrations changed toward negative with mydriasis in the participants' eyes suggesting the change of the ocular spherical aberration to be attributed to internal changes.

References

1. Cashell GT. A short history of spectacles. Proc R Soc Med. 1971; 64:1063–4.
crossref
2. Born M, Wolf E. Principles of optics, 7th ed. Cambridge: Cambridge University Press;1999. p. 523–5.
3. Molebny VV, Pallikaris IG, Naoumidis LP, et al. Retina ray-tracing technique for eye-refraction mapping. Proc SPIE. 1997; 2971:175–83.
4. Molebny VV, Panagopoulou SI, Molebny SV, et al. Principles of ray tracing aberrometry. J Refract Surg. 2000; 16:S572–5.
crossref
5. MacRae S, Fujieda M. Slit skiascopic-guided ablation using the Nidek laser. J Refract Surg. 2000; 16:S576–80.
crossref
6. Mrochen M, Kaemmerer M, Mierdel P, et al. Principles of Tscherning aberrometry. J Refract Surg. 2000; 16:S570–1.
crossref
7. Moreno-Barriuso E, Navarro R. Laser Ray Tracing versus Hartmann-Shack sensor for measuring optical aberrations in the human eye. J Opt Soc Am A Opt Image Sci Vis. 2000; 17:974–85.
crossref
8. Thibos LN. Principles of Hartmann-Shack aberrometry. J Refract Surg. 2000; 16:S563–5.
crossref
9. Liang J, Grimm B, Goelz S, Bille JF. Objective measurement of wave aberrations of the human eye with the use of a Hartmann-Shack wave-front sensor. J Opt Soc Am A Opt Image Sci Vis. 1994; 11:1949–57.
crossref
10. Ortiz D, Alió JL, Bernabéu G, Pongo V. Optical performance of monofocal and multifocal intraocular lenses in the human eye. J Cataract Refract Surg. 2008; 34:755–62.
crossref
11. Giessler S, Hammer T, Duncker GI. [Aberrometry due dilated pupilsWhich mydriatic should be used?]. Klin Monbl Augenheilkd. 2002; 219:655–9.
12. Carkeet A, Velaedan S, Tan YK, et al. Higher order ocular aberrations after cycloplegic and non-cycloplegic pupil dilation. J Refract Surg. 2003; 19:316–22.
crossref
13. Taneri S, Oehler S, Azar DT. Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer. J Refract Surg. 2011; 27:678–85.
crossref
14. Ahn SM, Seok SS, Park CY. Considering spherical aberration in choosing the wavefront map for laser vision correction. J Korean Ophthalmol Soc. 2011; 52:147–56.
crossref
15. Piñero DP, Juan JT, Alió JL. Intrasubject repeatability of internal aberrometry obtained with a new integrated aberrometer. J Refract Surg. 2011; 27:509–17.
crossref
16. Brown N. The change in shape and internal form of the lens of the eye on accommodation. Exp Eye Res. 1973; 15:441–59.
crossref
17. Dubbelman M, Van der Heijde GL, Weeber HA. Change in shape of the aging human crystalline lens with accommodation. Vision Res. 2005; 45:117–32.
crossref
18. Dubbelman M, Van der Heijde GL, Weeber HA, Vrensen GF. Changes in the internal structure of the human crystalline lens with age and accommodation. Vision Res. 2003; 43:2363–75.
crossref

Figure 1.
Comparison of spherical aberrations (SA) before and after mydriasis (in micrometer). The ocular and internal spherical aberrations were statistically significantly different on 6-mm diameter zone (p = 0.025, p = 0.002, respectively, paired t-test). Before = before mydriasis, at mesopic conditions, 8 lux; After = after pharmacologically induced mydriasis.
jkos-54-581f1.tif
Figure 2.
Comparison of high order aberrations (HOA) before and after mydriasis (in average root mean square; RMS). The high order aberrations did not change significantly after mydriasis. Before = before mydriasis, at mesopic conditions, 8 lux; After = after pharmacologically induced mydriasis.
jkos-54-581f2.tif
Figure 3.
Comparison of astigmatism (Astig.) before and after mydriasis (in diopter). The astigmatism did not change significantly after mydriasis. Before = before mydriasis, at mesopic conditions, 8 lux; After = after pharmacologically induced mydriasis.
jkos-54-581f3.tif
Table 1.
The average of ocular, corneal and internal spherical aberrations on 4-mm and 6-mm diameter zone before and after mydriasis. The ocular and internal spherical aberrations on 6-mm diameter zone were statistically significantly shifted in a negative direction after mydriasis
Pupil size Before* (μm) After (μm) p-value
4-mm Ocular SA 0.037 ± 0.035 0.038 ± 0.039 0.857
Corneal SA 0.052 ± 0.029 0.056 ± 0.029 0.343
Internal SA -0.014 ± 0.037 -0.019 ± 0.032 0.228
6-mm Ocular SA 0.26 ± 0.25 0.23 ± 0.25 0.025
Corneal SA 0.29 ± 0.21 0.32 ± 0.18 0.088
Internal SA -0.043 ± 0.21 -0.093 ± 0.17 0.002

Values are presented as mean ± SD.

SA = spherical aberrations.

* Before mydriasis, at mesopic conditions, 8 lux

After pharmacologically induced mydriasis.

Table 2.
The average of ocular, corneal and internal high order aberrations on 4-mm and 6-mm diameter zone before and after mydriasis. The high order aberrations were not statistically significantly different after mydriasis
Pupil size Before* (RMS) After (RMS) p-value
4-mm Ocular HOA 0.16 ± 0.084 0.16 ± 0.089 0.906
Corneal HOA 0.16 ± 0.071 0.15 ± 0.061 0.241
Internal HOA 0.13 ± 0.098 0.13 ± 0.097 0.945
6-mm Ocular HOA 0.54 ± 0.33 0.52 ± 0.33 0.139
Corneal HOA 0.48 ± 0.26 0.48 ± 0.26 0.921
Internal HOA 0.42 ± 0.24 0.39 ± 0.21 0.267

Values are presented as mean ± SD. HOA = high order aberrations.

* Before mydriasis, at mesopic conditions, 8 lux

After pharmacologically induced mydriasis

Average root mean square.

Table 3.
The average of ocular, corneal and internal astigmatism on 4-mm and 6-mm diameter zone before and after mydriasis. The astigmatism was not statistically significantly different after mydriasis
Pupil size Before* (D) After (D) p-value
4-mm Ocular Astig. -0.86 ± 0.49 -0.85 ± 0.46 0.936
Corneal Astig. -0.83 ± 0.54 -0.80 ± 0.54 0.409
Internal Astig. -0.65 ± 0.37 -0.70 ± 0.39 0.229
6-mm Ocular Astig. -0.92 ± 0.49 -0.95 ± 0.55 0.417
Corneal Astig. -0.65 ± 0.43 -0.63 ± 0.47 0.579
Internal Astig. -0.66 ± 0.39 -0.69 ± 0.43 0.427

Values are presented as mean ± SD. D = Diopters; Astig. = Astigmatism.

* Before mydriasis, at mesopic conditions, 8 lux

After pharmacologically induced mydriasis.

TOOLS
Similar articles